XERS Xeris Biopharma Holdings, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$9,08
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$5,2552-Wochen-Tief
$11,3352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.58B
P/E (TTM)
-90.8
EPS (TTM)
$-0.10
Umsatz (TTM)
$335M
Ihre Abzeichen
52W-Spanne
$5–$11
Analystenbewertung
BUY
Kursziel
$12
P/E
-90.8
ROE
118.2%
Nettogewinnmarge
-5.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
XERS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$9.08
Marktkapitalisierung (MRQ)
$1.58B
P/E (TTM)
-90.8
EPS (TTM)
$-0.10
Umsatz (TTM)
$335M
ROE (TTM)
118.2%
Verschuldungsgrad (MRQ)
-25.9
52W-Spanne
$5–$11
XERS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$292M2020-12-31 → 2025-12-31
EPS$0.002021-12-31 → 2025-12-31
Freier Cashflow·2021-12-31 → 2021-12-31
Nettogewinnmarge-5.1%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | XERS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -90.8 | · | · | · | |
| P/S (TTM) | 4.75-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 6.9 | Unterbewertet | |
| K/B (MRQ) | -161.95-Jahres-Durchschnitt ≈10.1 | ≈10.1 | · | · | |
| EV / EBITDA | 61.8 | · | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | 52.75-Jahres-Durchschnitt ≈8.3 | ≈8.3 | 11.3 | Überbewertet | |
| EV / Revenue (EV / Umsatz) | 5.5 | · | · | · | |
| Kurs / Materieller Buchwert (MRQ) | -17.1 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | XERS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 10.9%5-Jahres-Durchschnitt ≈-11.6% | ≈-11.6% | 5.6% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | 9.0%5-Jahres-Durchschnitt ≈-11.0% | ≈-11.0% | 4.1% | Spitzenklasse | |
| Pretax Margin (Vorgewinnmarge) | 0.19%5-Jahres-Durchschnitt ≈-22.2% | ≈-22.2% | 11.5% | Schwach | |
| Nettogewinnmarge (TTM) | -5.1%5-Jahres-Durchschnitt ≈-21.6% | ≈-21.6% | -13.6% | Unterdurchschnittlich | |
| ROA (TTM) | -4.6%5-Jahres-Durchschnitt ≈-11.9% | ≈-11.9% | -0.47% | Spitzenklasse | |
| ROE (TTM) | 118.2%5-Jahres-Durchschnitt ≈1479.3% | ≈1479.3% | -5.5% | Schwach | |
| ROIC | 10.6%5-Jahres-Durchschnitt ≈210.3% | ≈210.3% | 9.5% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | XERS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | -25.9 | · | 0.4 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.45-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 2.9 | Geringe Liquidität | |
| Quick Ratio | 1.55-Jahres-Durchschnitt ≈1.3 | ≈1.3 | 1.9 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | -19.4 | · | 0.4 | Geringe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | XERS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 43.7%5-Jahres-Durchschnitt ≈38.8% | ≈38.8% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 38.3%5-Jahres-Durchschnitt ≈66.2% | ≈66.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 70.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | XERS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.85-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.7 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 6.45-Jahres-Durchschnitt ≈5.4 | ≈5.4 | 6.4 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$670.9K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
29.2%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $-0.18 | $0.00 | — |
| 31. März 2026 | $0.01 | $-0.01 | — | |
| 31. Dezember 2025 | $0.06 | $0.04 | 33.6% | |
| 30. September 2025 | $0.00 | $0.00 | — | |
| 30. Juni 2025 | $-0.01 | $-0.03 | 64.4% | |
| 31. März 2025 | $-0.06 | $-0.05 | -10.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $292M | $203M | $164M | $110M | $50M | $20M | |
| R&D Expense | $31M | $26M | $22M | $21M | $25M | $21M | |
| SG&A Expense | $182M | $163M | $146M | $138M | $126M | $74M | |
| Operating Income | $25M | $-34M | $-44M | $-82M | $-115M | $-84M | |
| Interest Expense | · | · | $27M | $14M | $7M | $11M | |
| Other Non-op | $-24M | $-23M | $-19M | $-14M | $-8M | $-8M | |
| Pretax Income | $554.0K | $-57M | $-64M | $-96M | $-123M | · | |
| Income Tax | $0 | $-2M | $-1M | $-1M | $0 | $-110.0K | |
| Net Income | $554.0K | $-55M | $-62M | $-95M | $-123M | $-91M | |
| EPS (Basic) | $0.00 | $-0.37 | $-0.45 | $-0.70 | $-1.55 | · | |
| EPS (Diluted) | $0.00 | $-0.37 | $-0.45 | $-0.70 | $-1.55 | · | |
| Shares (Basic) | 160,425,198 | 146,772,758 | 137,674,857 | 135,628,721 | 79,027,062 | · | |
| Shares (Diluted) | 172,742,720 | 146,772,758 | 137,674,857 | 135,628,721 | 79,027,062 | · | |
| EBITDA | $26M | $-32M | $-43M | $-81M | $-114M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $72M | $67M | $122M | $67M | $38M | |
| Short-term Investments | · | $0 | $5M | $0 | $35M | $96M | |
| Receivables | $51M | $40M | $39M | $31M | $17M | $7M | |
| Inventory | $69M | $48M | $39M | $25M | $18M | $8M | |
| Prepaid Expense | $10M | $7M | $6M | $9M | $5M | $3M | |
| Current Assets | $240M | $168M | $156M | $187M | $143M | $152M | |
| PP&E (Net) | $5M | $6M | $6M | $6M | $7M | $7M | |
| PP&E (Gross) | $13M | $13M | $12M | $11M | $11M | $9M | |
| Accum. Depreciation | $8M | $7M | $6M | $6M | $4M | $3M | |
| Goodwill | $23M | $23M | $23M | $23M | $23M | $0 | |
| Intangibles | $88M | $99M | $110M | $121M | $131M | $0 | |
| Other Non-current Assets | $5M | $5M | $5M | $5M | $829.0K | $232.0K | |
| Total Assets | $384M | $323M | $323M | $345M | $304M | $159M | |
| Accounts Payable | $3M | $2M | $12M | $5M | $9M | $3M | |
| Accrued Liabilities | $33M | $28M | $24M | $37M | $49M | $16M | |
| Current Liabilities | $110M | $100M | $95M | $74M | $79M | $28M | |
| Capital Leases | $32M | $33M | $35M | $9M | $0 | · | |
| Deferred Tax | · | $0 | $2M | $4M | $5M | $0 | |
| Other Non-current Liabilities | $8M | $2M | $5M | $31.0K | $2M | $4M | |
| Total Liabilities | $370M | $353M | $329M | $299M | $209M | $125M | |
| Long-term Debt | $220M | $232M | $191M | $187M | $88M | $87M | |
| Total Debt | $220M | $232M | · | · | · | · | |
| Common Stock | $17.0K | $15.0K | $14.0K | $14.0K | $13.0K | $6.0K | |
| Paid-in Capital | $685M | $642M | $610M | $600M | $555M | $371M | |
| Retained Earnings | $-671M | $-672M | $-617M | $-555M | $-460M | $-337M | |
| AOCI | $-25.0K | $-25.0K | $-25.0K | $-23.0K | $-31.0K | $6.0K | |
| Stockholders' Equity | $14M | $-30M | $-7M | $45M | $95M | $34M | |
| Liabilities + Equity | $384M | $323M | $323M | $345M | $304M | $159M | |
| Shares Outstanding | 166,215,410 | 149,429,410 | 138,130,715 | 136,273,090 | 124,873,316 | 59,611,202 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $22M | $18M | $11M | $12M | $11M | $8M | |
| Deferred Tax | $0 | $-2M | $-1M | $-1M | $0 | · | |
| Amort. of Intangibles | $11M | $11M | $11M | $11M | $550.0K | $0 | |
| Other Non-cash | $4M | $533.0K | $4M | $-20M | $14M | · | |
| Operating Cash Flow | $29M | $-37M | $-47M | $-103M | $-96M | $-81M | |
| CapEx | · | · | · | · | $1M | $377.0K | |
| Investing Cash Flow | $-696.0K | $5M | $-6M | $34M | $98M | $-27M | |
| Debt Issued | · | $0 | $0 | $146M | $0 | $95M | |
| Net Debt Issued | · | $0 | $0 | $103M | $0 | · | |
| Stock Issued | · | $0 | $0 | $30M | $27M | $66M | |
| Net Stock Activity | · | $0 | $0 | $30M | $27M | · | |
| Financing Cash Flow | $11M | $36M | $-2M | $127M | $27M | $126M | |
| Net Change in Cash | $39M | $4M | $-55M | $59M | $30M | $18M | |
| Free Cash Flow | · | · | · | · | $-97M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | 8.5% | -16.6% | -26.9% | -74.3% | -232.2% | · | |
| Net Margin | 0.19% | -27.0% | -38.0% | -85.9% | -247.5% | · | |
| Pretax Margin | 0.19% | -28.1% | -38.7% | · | · | · | |
| EBITDA Margin | 9.0% | -16.0% | -25.9% | -73.0% | -229.5% | · | |
| ROA | 0.16% | -16.6% | -19.1% | -29.2% | -52.9% | · | |
| ROE | -19.7% | 189.3% | 4268.4% | -188.9% | -264.6% | · | |
| ROIC | 10.6% | -16.0% | 636.2% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 1.7 | 1.6 | 2.5 | 1.8 | · | |
| Quick Ratio | 1.5 | 1.1 | 1.2 | 2.1 | 1.5 | · | |
| Debt / Equity | 16.1 | -7.8 | · | · | · | · | |
| LT Debt / Equity | 16.1 | -7.3 | · | · | · | · | |
| Interest Coverage | · | · | -1.7 | -5.3 | -16.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.6 | 0.5 | 0.3 | 0.2 | · | |
| Receivables Turnover | 6.4 | 5.2 | 4.7 | 4.6 | 4.1 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $-0.20 | $-0.05 | $0.33 | · | · | |
| Revenue / Share | $1.69 | $1.38 | $1.19 | $0.81 | · | · | |
| Cash Flow / Share | $0.17 | $-0.25 | $-0.34 | $-0.76 | · | · | |
| Cash / Share | $0.67 | $0.48 | $0.49 | $0.90 | · | · | |
| EPS (TTM) | $0.00 | $-0.37 | $-0.45 | $-0.70 | $-1.55 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 43.7% | 23.9% | 48.7% | 122.3% | 142.7% | · | |
| Revenue CAGR 3Y | 38.3% | 60.0% | 100.2% | · | · | · | |
| Revenue CAGR 5Y | 70.2% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $292M | $203M | $164M | $110M | $50M | · | |
| Net Income TTM | $554.0K | $-55M | $-62M | $-95M | $-123M | · | |
| Market Cap | $1.30B | $507M | $325M | $181M | · | · | |
| Enterprise Value | $1.41B | $667M | · | · | · | · | |
| P/E | · | -9.2 | -5.2 | -1.9 | -1.9 | · | |
| P/S | 4.5 | 2.5 | 2.0 | 1.6 | · | · | |
| P/B | 95.3 | -17.1 | -47.9 | 4.0 | · | · | |
| P / Cash Flow | 45.6 | -13.7 | -6.9 | -1.8 | · | · | |
| EV / EBITDA | 54.0 | -20.6 | · | · | · | · | |
| EV / Revenue | 4.8 | 3.3 | · | · | · | · | |
| Earnings Yield | 0.00% | -10.9% | -19.1% | -52.6% | -52.9% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $92M | $83M | $86M | $74M | $72M | $60M | $60M | $54M | $48M | $41M | $44M | $48M | $38M | $33M | $33M | $30M | |
| R&D Expense | $11M | $9M | $8M | $7M | $8M | $8M | $6M | $6M | $6M | $8M | $6M | $5M | $6M | $5M | $5M | $6M | |
| SG&A Expense | $61M | $53M | $48M | $46M | $44M | $44M | $40M | $45M | $40M | $38M | $38M | $37M | $38M | $34M | $34M | $34M | |
| Operating Income | $5M | $8M | $17M | $7M | $4M | $-3M | $2M | $-13M | $-8M | $-14M | $-10M | $-5M | $-16M | $-13M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $7M | $7M | $6M | · | $4M | |
| Other Non-op | $-36M | $-6M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-6M | $-4M | $-4M | $-8M | $-5M | $-4M | $2M | $-3M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-3M | $749.0K | $307.0K | $-236.0K | $-338.0K | $-675.0K | $0 | $-338.0K | $-339.0K | |
| Net Income | $-31M | $2M | $11M | $621.0K | $-2M | $-9M | $-5M | $-16M | $-15M | $-19M | $-13M | $-12M | $-20M | $-17M | $-13M | $-22M | |
| EPS (Basic) | $-0.18 | $0.01 | $0.07 | $0.00 | $-0.01 | $-0.06 | $-0.02 | $-0.11 | $-0.10 | $-0.14 | $-0.10 | $-0.09 | $-0.14 | $-0.12 | $-0.10 | $-0.16 | |
| EPS (Diluted) | $-0.18 | $0.01 | $0.07 | $0.00 | $-0.01 | $-0.06 | $-0.02 | $-0.11 | $-0.10 | $-0.14 | $-0.10 | $-0.09 | $-0.14 | $-0.12 | $-0.10 | $-0.16 | |
| Shares (Basic) | 172,823,455 | 170,523,208 | · | 163,649,932 | 159,459,413 | 152,445,935 | · | 148,993,823 | 148,345,549 | 140,513,907 | · | 138,059,781 | 137,338,071 | 137,142,565 | · | 135,951,761 | |
| Shares (Diluted) | 172,823,455 | 177,631,154 | · | 177,617,307 | 159,459,413 | 152,445,935 | · | 148,993,823 | 148,345,549 | 140,513,907 | · | 138,059,781 | 137,338,071 | 137,142,565 | · | 135,951,761 | |
| EBITDA | $5M | $8M | · | $7M | $4M | $-3M | · | $-13M | $-8M | $-14M | · | $-5M | $-16M | $-13M | · | $-19M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $122M | $112M | $111M | $92M | $59M | $58M | $72M | $59M | $58M | · | $67M | $46M | · | · | · | $84M | |
| Short-term Investments | · | · | · | · | · | · | · | $10M | $20M | · | · | $20M | · | · | · | $9M | |
| Receivables | $58M | $56M | $51M | $54M | $53M | $46M | $40M | $41M | $42M | · | · | $46M | · | · | · | $28M | |
| Inventory | $81M | $74M | $69M | $67M | $67M | $53M | $48M | $45M | $43M | · | · | $38M | · | · | · | $20M | |
| Prepaid Expense | $14M | $9M | $10M | $11M | $6M | $6M | $7M | $7M | $7M | · | · | $8M | · | · | · | $8M | |
| Current Assets | $275M | $252M | $240M | $224M | $186M | $163M | $168M | $163M | $170M | · | · | $158M | · | · | · | $149M | |
| PP&E (Net) | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | · | · | $6M | · | · | · | $6M | |
| PP&E (Gross) | $14M | $14M | $13M | $13M | $13M | $13M | $13M | $13M | $12M | · | · | $12M | · | · | · | $11M | |
| Accum. Depreciation | $9M | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | · | · | $6M | · | · | · | $5M | |
| Goodwill | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | · | · | $23M | · | · | · | $23M | |
| Intangibles | $83M | $85M | $88M | $91M | $94M | $96M | $99M | $102M | $104M | · | · | $112M | · | · | · | $123M | |
| Other Non-current Assets | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | · | $5M | · | · | · | $2M | |
| Total Assets | $412M | $392M | $384M | $370M | $335M | $315M | $323M | $321M | $332M | · | · | $328M | · | · | · | $303M | |
| Accounts Payable | $9M | $11M | $3M | $7M | $9M | $6M | $2M | $7M | $6M | · | · | $12M | · | · | · | $4M | |
| Accrued Liabilities | $40M | $32M | $33M | $30M | $25M | $20M | $28M | $24M | $23M | · | · | $19M | · | · | · | $38M | |
| Current Liabilities | $190M | $119M | $110M | $116M | $95M | $95M | $100M | $91M | $75M | · | · | $87M | · | · | · | $69M | |
| Capital Leases | $31M | $31M | $32M | $32M | $32M | $33M | $33M | $34M | $34M | · | · | $35M | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | $3M | · | · | $3M | · | · | · | $4M | |
| Other Non-current Liabilities | $13M | $8M | $8M | $3M | $8M | $5M | $2M | $9M | $8M | · | · | $4M | · | · | · | $311.0K | |
| Total Liabilities | $422M | $379M | $370M | $371M | $354M | $351M | $353M | $349M | $351M | · | · | $324M | · | · | · | $248M | |
| Long-term Debt | $253M | $221M | $220M | $219M | $219M | $230M | $232M | $216M | $230M | · | · | $190M | · | · | · | $139M | |
| Total Debt | $253M | · | · | $219M | $219M | $230M | · | $15M | · | · | · | · | · | · | · | · | |
| Common Stock | $18.0K | $18.0K | $17.0K | $17.0K | $16.0K | $16.0K | $15.0K | $15.0K | $15.0K | · | · | $14.0K | · | · | · | $14.0K | |
| Paid-in Capital | $690M | $682M | $685M | $682M | $664M | $646M | $642M | $638M | $632M | · | · | $608M | · | · | · | $597M | |
| Retained Earnings | $-700M | $-669M | $-671M | $-682M | $-683M | $-681M | $-672M | $-667M | $-651M | · | · | $-604M | · | · | · | $-542M | |
| AOCI | $-10.0K | $-24.0K | $-25.0K | $-25.0K | $-24.0K | $-25.0K | $-25.0K | $-16.0K | $-31.0K | · | · | $-50.0K | · | · | · | $-37.0K | |
| Stockholders' Equity | $-10M | $13M | $14M | $-861.0K | $-19M | $-35M | $-30M | $-28M | $-19M | · | $-7M | $4M | · | · | $45M | $55M | |
| Liabilities + Equity | $412M | $392M | $384M | $370M | $335M | $315M | $323M | $321M | $332M | · | · | $328M | · | · | · | $303M | |
| Shares Outstanding | 173,591,637 | 172,558,783 | 166,215,410 | 165,528,253 | 161,224,762 | 156,014,050 | 149,429,410 | 149,003,934 | 148,936,727 | · | · | 138,067,806 | · | · | · | 135,961,552 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $337.0K | $335.0K | $338.0K | $325.0K | $315.0K | $313.0K | $307.0K | $281.0K | $326.0K | $346.0K | $391.0K | $386.0K | $364.0K | $366.0K | $360.0K | |
| Stock-based Comp | · | $4M | $5M | $8M | $5M | $4M | $4M | $7M | $4M | $4M | $3M | $2M | $3M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $0 | $-3M | $749.0K | $307.0K | $-1M | $675.0K | $-675.0K | $0 | · | · | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-cash | · | $3M | · | · | · | $-6M | · | · | · | $-6M | · | · | · | $-12M | · | · | |
| Operating Cash Flow | · | $10M | $20M | $18M | $182.0K | $-10M | $2M | $-8M | $-10M | $-20M | $7M | $-15M | $-14M | $-26M | $-16M | $-18M | |
| Investing Cash Flow | · | $-325.0K | $-333.0K | $-71.0K | $-279.0K | $-13.0K | $10M | $10M | $5M | $-20M | $15M | $15M | $8M | $-44M | $9M | $7M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $49M | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | · | $-9M | $-266.0K | $14M | $942.0K | $-3M | $398.0K | $-83.0K | $659.0K | $35M | $-1M | $-72.0K | $556.0K | $-863.0K | $49M | $-187.0K | |
| Net Change in Cash | · | $708.0K | $19M | $32M | $845.0K | $-13M | $12M | $2M | $-5M | $-5M | $21M | $-27.0K | $-5M | $-71M | $42M | $-11M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 5.6% | 9.5% | · | 9.0% | 6.3% | -5.1% | · | -23.8% | -17.0% | -35.0% | · | -10.2% | -42.0% | -40.0% | · | -63.2% | |
| Net Margin | -33.8% | 2.7% | · | 0.83% | -2.7% | -15.3% | · | -29.0% | -31.2% | -46.7% | · | -25.2% | -52.2% | -50.7% | · | -73.4% | |
| EBITDA Margin | 5.6% | 9.9% | · | 9.0% | 6.3% | -4.6% | · | -23.8% | -17.0% | -34.2% | · | -10.2% | -42.0% | -38.9% | · | -63.2% | |
| ROA | -8.3% | · | · | 0.18% | -0.58% | -2.8% | · | -4.9% | -4.6% | · | · | -3.9% | · | · | · | -10.1% | |
| ROE | 214.2% | · | · | -4.3% | 10.0% | -30.1% | · | 128.7% | -54.9% | · | · | -41.4% | · | · | · | -83.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | · | · | 1.9 | 1.9 | 1.7 | · | 1.8 | 2.3 | · | · | 1.8 | · | · | · | 2.2 | |
| Quick Ratio | 0.9 | · | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.6 | · | · | 1.3 | · | · | · | 1.8 | |
| Debt / Equity | -25.9 | · | · | -254.9 | -11.3 | -6.5 | · | -0.5 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | -19.4 | · | · | -254.9 | -11.3 | -6.2 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -2.0 | · | -0.7 | -2.4 | -2.1 | · | -4.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | · | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | · | · | 0.2 | · | · | · | 0.1 | |
| Receivables Turnover | 1.7 | · | · | 1.6 | 1.5 | 1.7 | · | 1.2 | 1.4 | · | · | 1.3 | · | · | · | 2.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.06 | · | · | $-0.01 | $-0.12 | $-0.23 | · | $-0.19 | $-0.13 | · | · | $0.03 | · | · | · | $0.40 | |
| Revenue / Share | $0.53 | $0.47 | · | $0.42 | $0.45 | $0.39 | · | $0.36 | $0.32 | $0.29 | · | $0.35 | $0.28 | $0.24 | · | $0.22 | |
| Cash Flow / Share | · | $0.06 | · | · | · | $-0.07 | · | · | · | $-0.14 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $0.70 | · | · | $0.55 | $0.37 | $0.37 | · | $0.40 | $0.39 | · | · | $0.33 | · | · | · | $0.62 | |
| EPS (TTM) | $-0.10 | $-0.06 | · | · | · | · | · | $-0.45 | $-0.43 | $-0.47 | · | $-0.45 | $-0.52 | $-0.57 | · | $-1.05 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $335M | $289M | · | · | · | · | · | $187M | $181M | $171M | · | $153M | $134M | $121M | · | $99M | |
| Net Income TTM | · | $-8M | · | · | · | · | · | $-63M | $-60M | $-64M | · | $-62M | $-71M | $-78M | · | $-133M | |
| Market Cap | $1.37B | · | · | $1.35B | $753M | $857M | · | $425M | $335M | · | · | $257M | · | · | · | $212M | |
| Enterprise Value | $1.51B | · | · | $1.48B | $912M | $1.03B | · | $370M | · | · | · | · | · | · | · | · | |
| P/E | -79.2 | -96.7 | · | · | · | · | · | -6.3 | -5.2 | -4.7 | · | -4.1 | -5.0 | -2.9 | · | -1.5 | |
| P/S | 4.1 | · | · | · | · | · | · | 2.3 | 1.8 | · | · | 1.7 | · | · | · | 2.2 | |
| P/B | -141.2 | · | · | -1564.9 | -39.0 | -24.4 | · | -15.0 | -17.4 | · | · | 66.4 | · | · | · | 3.9 | |
| P / Cash Flow | · | · | · | · | · | -85.4 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 4.5 | · | · | · | · | · | · | 2.0 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.3% | -1.0% | · | · | · | · | · | -15.8% | -19.1% | -21.3% | · | -24.2% | -19.9% | -35.0% | · | -67.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2023-06-30 |
|---|---|---|---|---|---|
| Umsatz | $292M | $203M | · | $164M | · |
| Betriebsgewinnmarge % | 8.5% | -16.6% | · | -26.9% | · |
| Nettoergebnis | $554.0K | $-55M | · | $-62M | · |
| Verwässerte EPS | $0.00 | $-0.37 | · | $-0.45 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2023-06-30 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 16.1 | -7.8 | · | · | · |
| Liquiditätsgrad | 2.2 | 1.7 | · | 1.6 | · |
| Quick Ratio | 1.5 | 1.1 | · | 1.2 | · |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 255 Einreicher · $950.7M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
255
Gehaltener Wert
$950.7M
Neue Positionen
35
Geschlossene Positionen
25
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 35 (-15 vs. Vorquartal) | 25 (-8 vs. Vorquartal) | 104 (+4 vs. Vorquartal) | 68 (+14 vs. Vorquartal) | +2.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $115.042.270 | 14.525.539 | 12,10% | Aktien |
| VANGUARD GROUP INC | $87.815.416 | 11.186.677 | 9,24% | Aktien |
| D. E. Shaw & Co., Inc. | $61.813.683 | 7.804.758 | 6,50% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $58.134.614 | 7.340.229 | 6,11% | Aktien |
| STATE STREET CORP | $38.186.803 | 4.821.566 | 4,02% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $37.374.872 | 4.718.183 | 3,93% | Aktien |
| Nuveen, LLC | $34.730.316 | 4.385.141 | 3,65% | Aktien |
| Rosalind Advisors, Inc. | $23.039.130 | 2.908.981 | 2,42% | Aktien |
| Qube Research & Technologies Ltd | $22.918.492 | 2.893.749 | 2,41% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.799.567 | 2.626.208 | 2,19% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $18.731.616 | 2.365.103 | 1,97% | Aktien |
| MORGAN STANLEY | $18.509.800 | 2.337.096 | 1,95% | Aktien |
| Legal & General Group Plc | $15.941.313 | 2.012.792 | 1,68% | Aktien |
| ARMISTICE CAPITAL, LLC | $15.512.920 | 1.958.702 | 1,63% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $14.933.184 | 1.885.503 | 1,57% | Aktien |
| Parkman Healthcare Partners LLC | $14.316.358 | 1.807.621 | 1,51% | Aktien |
| ALGERT GLOBAL LLC | $13.804.101 | 1.742.942 | 1,45% | Aktien |
| NORTHERN TRUST CORP | $12.654.172 | 1.597.749 | 1,33% | Aktien |
| GOLDMAN SACHS GROUP INC | $12.625.051 | 1.594.072 | 1,33% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $12.204.601 | 1.540.985 | 1,28% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.819.547 | 1.492.367 | 1,24% | Aktien |
| FEDERATED HERMES, INC. | $11.360.709 | 1.434.433 | 1,19% | Aktien |
| BANK OF AMERICA CORP /DE/ | $11.064.636 | 1.397.050 | 1,16% | Aktien |
| UBS Group AG | $10.303.231 | 1.300.913 | 1,08% | Aktien |
| Ishara Investments LP | $9.741.600 | 1.230.000 | 1,02% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $9.697.232 | 1.224.398 | 1,02% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $9.575.819 | 1.209.068 | 1,01% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $8.503.221 | 1.073.639 | 0,89% | Aktien |
| Knott David M Jr | $8.395.200 | 1.060.000 | 0,88% | Aktien |
| JPMORGAN CHASE & CO | $8.189.439 | 1.058.067 | 0,86% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $7.705.210 | 972.880 | 0,81% | Aktien |
| Granahan Investment Management, LLC | $7.118.124 | 898.753 | 0,75% | Aktien |
| TWO SIGMA ADVISERS, LP | $6.667.272 | 849.334 | 0,70% | Aktien |
| NORGES BANK | $6.313.824 | 797.200 | 0,66% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $5.667.615 | 715.608 | 0,60% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $5.429.714 | 685.570 | 0,57% | Aktien |
| CITADEL ADVISORS LLC | $5.263.347 | 664.564 | 0,55% | Aktien |
| FMR LLC | $5.100.933 | 644.057 | 0,54% | Aktien |
| Walleye Capital LLC | $4.841.464 | 611.296 | 0,51% | Aktien |
| DEUTSCHE BANK AG\ | $4.193.189 | 529.443 | 0,44% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $3.874.829 | 668.074 | 0,41% | Aktien |
| Bank of New York Mellon Corp | $3.868.454 | 488.441 | 0,41% | Aktien |
| FIRST TRUST ADVISORS LP | $3.841.025 | 484.978 | 0,40% | Aktien |
| IHT Wealth Management, LLC | $3.816.418 | 481.871 | 0,40% | Aktien |
| PERCEPTIVE ADVISORS LLC | $3.698.743 | 467.013 | 0,39% | Aktien |
| ROYCE & ASSOCIATES LP | $3.652.332 | 461.153 | 0,38% | Aktien |
| Man Group plc | $3.606.610 | 455.380 | 0,38% | Aktien |
| Caption Management, LLC | $3.512.520 | 443.500 | 0,37% | Verkaufsoption |
| Russell Investments Group, Ltd. | $3.490.591 | 440.731 | 0,37% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $3.409.465 | 430.488 | 0,36% | Aktien |
Unternehmensinsider 18 Insider · 8 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John Patrick Shannon Jr | Chief Executive Officer and Chairman of the Board | 1. August 2026 F | 2.898.933 | 0 | 2 | $-349.727 |
| Paul R Edick | Chairman and Chief Executive Officer | 31. Januar 2024 A | 3.788.064 | 0 | 0 | $0 |
| Steven Pieper | Chief Financial Officer | 1. Oktober 2026 S | 1.351.053 | 0 | 5 | $-515.102 |
| Kevin Mcculloch | President and Chief Operating Officer | 1. Oktober 2026 S | 1.599.208 | 0 | 6 | $-1.481.500 |
| Beth Hecht | Chief Legal Officer and Corporate Secretary | 1. Oktober 2026 S | 1.111.130 | 0 | 13 | $-1.462.577 |
| Anh Tu Nguyen | Chief Medical Officer | 24. Februar 2026 F | 395.023 | 0 | 0 | $0 |
| Kenneth Erland Johnson | Senior Vice President, Global Development and Medical Affairs | 31. Januar 2025 F | 320.446 | 0 | 0 | $0 |
| Steven Prestrelski | Chief Scientific Officer | 31. Januar 2023 A | 719.780 | 0 | 0 | $0 |
| Nerissa Kreher | Direktor | 1. Juli 2026 A | 33.582 | 0 | 0 | $0 |
| James Aloysius Brady | Direktor | 4. Juni 2026 A | 113.359 | 0 | 1 | $-60.020 |
| Dawn Halkuff | Direktor | 4. Juni 2026 A | 119.193 | 0 | 1 | $-121.800 |
| Barbara-Jean Anne Bormann-Kennedy | Direktor | 4. Juni 2026 A | 150.693 | 0 | 2 | $-203.790 |
| Garheng Kong | Direktor | 4. Juni 2026 A | 238.337 | 0 | 0 | $0 |
| John Johnson | Direktor | 4. Juni 2026 A | 707.276 | 0 | 1 | $-91.350 |
| Marla Persky | Direktor | 4. Juni 2026 A | 150.693 | 0 | 1 | $-91.450 |
| Jeffrey W Sherman | Direktor | 28. August 2025 M | 219.188 | 0 | 0 | $0 |
| John P. Schmid | Direktor | 12. August 2024 P | 25.200 | 0 | 0 | $0 |
| Ricki Louise Fairley | Direktor | 5. Juni 2024 A | 135.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 34 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,64% | 199.875 NS | 31. Juli 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,06% | 27.065 NS | 31. Juli 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,75% | 335.210 NS | 31. Juli 2026 | N-PORT |
| ABLS · Abacus FCF ETF Trust | 0,66% | 380 NS | 31. Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,55% | 886.418 NS | 31. Juli 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,50% | 644.770 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,49% | 217.193 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,31% | 581.968 SH | 11. September 2026 | Täglich |
| IHE · iShares Trust | 0,30% | 639.408 SH | 11. September 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,19% | 330.430 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,11% | 12.893 SH | 2. Oktober 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 80.301 NS | 31. Juli 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,10% | 319.842 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,09% | 1.599.956 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 183.914 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,04% | 82.092 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 4.374.051 SH | 11. September 2026 | Täglich |
| ISCG · iShares Trust | 0,04% | 51.092 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 986.945 SH | 19. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 6.460 SH | 2. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.985.911 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 508.653 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 80.356 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,02% | 353.351 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 7.894 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 8.551 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 229.876 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 47.281 SH | 10. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 32.852 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 35.241 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4.518 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.193.656 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.864 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 7.243 SH | 11. September 2026 | Täglich |
XERS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$12.00
+32,2%
5 38,5%
Starker Kauf
6 46,2%
Kauf
2 15,4%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-09-29Mittelwert-Ziel $12.29 +35,3%
Jetzt
Aktueller Preis $9.08
Tief$8.00
Mittelwert$12.29
Hoch$18.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| XERS | $1.30B | · | 43.7% | 0.19% | -19.7% | · |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | · |
| PAHC | · | 12.9 | 17.1% | 6.6% | 29.7% | 33.8% |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | · |
| INVA | · | 6.1 | 14.7% | · | · | · |
| MAZE | $2.04B | -13.6 | · | · | -598.9% | · |
| KARD | · | · | · | · | · | · |
| OMER | $1.23B | -343.6 | · | · | 1.9% | · |
| AVLN | · | · | · | · | · | · |
| LBRX | $563M | -7.1 | · | · | -25.5% | · |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026